San Raffaele EoE Biobank
EoEBiobank
1 other identifier
observational
500
1 country
1
Brief Summary
Eosinophilic Esophagitis (EoE) is a immuno-mediated disease, characterised by a Th-2 food-antigen driven chronic inflammatory response of the esophagus. Main symptoms are dysphagia and food bolus impaction, frequently overlapping with most atypical and general symptoms like heartburn or regurgitation and difficulty to thrive in children. Overall incidence and prevalence of EoE are rapidly increasing. The complete comprehension of pathogenetic and molecular mechanism underlying this complex and relatively new disease is still to be conquered. For this reason, we created this EoE Biobank, in order to collect blood, oral and esophageal tissue samples of proven EoE patients to further exploit new insights of this disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2023
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 31, 2023
CompletedFirst Posted
Study publicly available on registry
June 9, 2023
CompletedStudy Start
First participant enrolled
September 12, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2026
CompletedAugust 14, 2023
August 1, 2023
2.7 years
May 31, 2023
August 8, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Molecular characterization of eosinophilic esophagitis
Transcriptomic, meta-transcriptomic and molecular staining of different biologic tissues of EoE patients
June 1st 2023 to June 1 st 2026
Interventions
During routine EGD, biopsy, blood and buccal saliva samples will be withdraw and stored at San Raffaele Hospital
Eligibility Criteria
Every male or female patient \> 16 years pertaining to IRCCS San Raffaele Hospital in Milan
You may qualify if:
- EoE diagnosis proven histologically with clinical activity
- Age \> 16 years
You may not qualify if:
- Not signed informed consent
- No definite EoE diagnosis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
IRCCS San Raffaele Hospital
Milan, Milano, 20132, Italy
Biospecimen
Blood, saliva and esophageal tissues
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 3 Years
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
May 31, 2023
First Posted
June 9, 2023
Study Start
September 12, 2023
Primary Completion
June 1, 2026
Study Completion
June 1, 2026
Last Updated
August 14, 2023
Record last verified: 2023-08
Data Sharing
- IPD Sharing
- Will not share